Mitochondrial Dysfunction as a Pathogenesis and Therapeutic Strategy for Metabolic-Dysfunction-Associated Steatotic Liver Disease
International Journal of Molecular Sciences · 30.04.2025 · 26 (9) · 4256
DOI: 10.3390/ijms26094256 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.04.2025. Verfasst von Xiangqiong Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming 650500, China. Hauptthemen laut MEDLINE: Mitochondria, Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhua Shi, Zhuangzhuang Jia, National Natural Science Foundation of China Regional Program.
Abstract (Originalsprache)
Metabolic-dysfunction-associated steatotic liver disease (MASLD) has emerged as a significant public health concern, attributed to its increasing prevalence and correlation with metabolic disorders, including obesity and type 2 diabetes. Recent research has highlighted that mitochondrial dysfunction can result in the accumulation of lipids in non-adipose tissues, as well as increased oxidative stress and inflammation. These factors are crucial in advancing the progression of MASLD. Despite advances in the understanding of MASLD pathophysiology, challenges remain in identifying effective therapeutic strategies targeting mitochondrial dysfunction. This review aims to consolidate current knowledge on how mitochondrial imbalance affects the development and progression of MASLD, while addressing existing research gaps and potential avenues for future research. This review was conducted after a systematic search of comprehensive academic databases such as PubMed, Embase, and Web of Science to gather information on mitochondrial dysfunction as well as mitochondrial-based treatments for MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming 650500, China.
- Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Kunming 650500, China.
- Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Kunming 650500, China.
- The First Clinical College of Yunnan University of Chinese Medicine, Kunming 650500, China.
ORCID-Profile: Xiangqiong Li, Zhuangzhuang Jia, Yahui Xiao
Förderung
- Anhua Shi
- Zhuangzhuang Jia
- National Natural Science Foundation of China Regional Program
- Yunnan Provincial Department of Science and Technology Joint Special Project of Traditional Chinese Medicine—Key Project
- Basic Research Program of Yunnan Provincial Science and Technology Department
- Project of Scientific Research Fund of Yunnan Provincial Department of Education
- Innovative Scientific Research Project of “key support and characteristic discipline of Yunnan first-class discipline—traditional Chinese Medicine”
- Open Fund Program of Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment
Zitieren
APA
Li, X., Chen, W., Jia, Z., Xiao, Y., Shi, A., & Ma, X. (2025). Mitochondrial Dysfunction as a Pathogenesis and Therapeutic Strategy for Metabolic-Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences, 26(9), 4256. https://doi.org/10.3390/ijms26094256
Vancouver
Li X, Chen W, Jia Z, Xiao Y, Shi A, Ma X. Mitochondrial Dysfunction as a Pathogenesis and Therapeutic Strategy for Metabolic-Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences. 2025;26(9):4256. doi:10.3390/ijms26094256
BibTeX
@article{Li2025,
author = {Li, Xiangqiong and Chen, Wenling and Jia, Zhuangzhuang and Xiao, Yahui and Shi, Anhua and Ma, Xuan},
title = {Mitochondrial Dysfunction as a Pathogenesis and Therapeutic Strategy for Metabolic-Dysfunction-Associated Steatotic Liver Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {9},
pages = {4256},
doi = {10.3390/ijms26094256}
}
EUVIMED